查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1878837

功能基因體學市場－全球產業規模、佔有率、趨勢、機會和預測，依產品、技術、應用、最終用戶、地區和競爭格局分類，2020-2030年預測

Functional Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technology, By Application, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球功能基因體學市場規模為104.3億美元，預計2030年將以9.30%的複合年成長率成長至177.8億美元。功能基因組學是對生物體內基因和蛋白質功能及其相互作用進行系統研究，以闡明生物過程和表現型表達。該市場的成長主要得益於高通量測序技術的進步、基因組研究投資的增加以及全球對個人化醫療和標靶治療日益成長的需求。此外，慢性病和遺傳性疾病的日益普遍也極大地推動了對先進基因組學知識和診斷工具的需求。

市場概覽
預測期 2026-2030
2024年市場規模 104.3億美元
2030年市場規模 177.8億美元
2025-2030年複合年成長率 9.3%
成長最快的細分市場 試劑盒和檢測
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球功能基因體學市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品分類（試劑盒及檢測方法、儀器）
    • 依技術分類（次世代定序 (NGS)、聚合酶鍊式反應 (PCR)、微陣列、其他技術）
    • 依應用領域（表觀基因體學、轉錄體學、蛋白質體學、代謝體學）
    • 按最終用戶分類（學術和研究機構、生物技術和生物製藥公司、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美功能基因體學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲功能基因體學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太功能基因體學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲功能基因體學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲功能基因體學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球功能基因體學市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation (Integrated DNA Technologies, Inc.)
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • MRM Proteomics Inc
  • Perkin Elmer, Inc.
  • QIAGEN NV
  • ¬¬¬Thermo Fisher Scientific, Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 17125

The Global Functional Genomics Market, valued at USD 10.43 Billion in 2024, is projected to experience a CAGR of 9.30% to reach USD 17.78 Billion by 2030. Functional genomics involves the systematic investigation of gene and protein functions and their interactions within an organism to elucidate biological processes and phenotypic expression. The market's expansion is fundamentally driven by advancements in high-throughput sequencing technologies, increasing investments in genomic research, and the escalating global demand for personalized medicine and targeted therapies. Furthermore, the growing prevalence of chronic diseases and genetic disorders contributes significantly to the imperative for advanced genomic understanding and diagnostic tools.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 10.43 Billion
Market Size 2030USD 17.78 Billion
CAGR 2025-20309.3%
Fastest Growing SegmentKits & Assays
Largest MarketNorth America

Key Market Drivers

The Global Functional Genomics Market is significantly influenced by ongoing technological advancements in genomic sequencing, which continuously enhance the efficiency and accessibility of genetic analysis. Breakthroughs in sequencing platforms have dramatically reduced the cost and increased the speed of generating genomic data, enabling researchers to conduct studies at an unprecedented scale. For instance, according to *Next-Generation Sequencing Costs: The Sub $100 Genome*, in September 2024, Complete Genomics released the DNBSEQ-T20x2 sequencing platform, capable of producing 50,000 whole genome sequences per year for less than $100 per 30x human genome. This reduction makes population-scale functional genomics projects more feasible, fostering a deeper understanding of gene function in health and disease and driving the discovery of new therapeutic targets and biomarkers. The increased throughput allows for more extensive experimental designs, moving beyond single-gene studies to comprehensive functional analyses across entire genomes or transcriptomes.

Key Market Challenges

A significant challenge impeding the growth of the Global Functional Genomics Market is the substantial initial investment and ongoing operational costs associated with its specialized technologies and required expertise. These financial demands directly limit market adoption, particularly among smaller research institutions and emerging biotechnology firms. Such entities frequently lack the extensive capital resources necessary to acquire high-throughput sequencing platforms, establish robust bioinformatics infrastructure, and recruit skilled personnel essential for functional genomics research. This financial barrier restricts overall market expansion by reducing the number of active participants and the volume of genomic studies undertaken globally.

Key Market Trends

The integration of Artificial Intelligence and Machine Learning for genomic analysis represents a significant trend in the Global Functional Genomics Market, transforming how complex biological data is interpreted and utilized. These technologies enhance the precision and speed of identifying gene functions, understanding disease mechanisms, and discovering therapeutic targets by processing vast datasets that would be unmanageable through traditional methods. According to a Pistoia Alliance survey conducted in October 2025, 77% of life sciences laboratories anticipate using AI within the next two years, with AI remaining the top investment area for 63% of respondents for the third consecutive year. This demonstrates a strong industry commitment to leveraging AI for advanced genomic insights.

Key Market Players

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation (Integrated DNA Technologies, Inc.)
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • MRM Proteomics Inc
  • Perkin Elmer, Inc.
  • QIAGEN N.V.
  • ¬¬¬Thermo Fisher Scientific, Inc.

Report Scope:

In this report, the Global Functional Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Functional Genomics Market, By Product:

  • Kits & Assays
  • Instruments

Functional Genomics Market, By Technology:

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Other Technologies

Functional Genomics Market, By Application:

  • Epigenomics
  • Transcriptomics
  • Proteomics
  • Metabolomics

Functional Genomics Market, By End-User:

  • Academic and Research Institutions
  • Biotechnology and Biopharmaceutical Companies
  • Others

Functional Genomics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Functional Genomics Market.

Available Customizations:

Global Functional Genomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Functional Genomics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Kits & Assays, Instruments)
    • 5.2.2. By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Other Technologies)
    • 5.2.3. By Application (Epigenomics, Transcriptomics, Proteomics, Metabolomics)
    • 5.2.4. By End-User (Academic and Research Institutions, Biotechnology and Biopharmaceutical Companies, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Functional Genomics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By End-User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Functional Genomics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End-User
    • 6.3.2. Canada Functional Genomics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End-User
    • 6.3.3. Mexico Functional Genomics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End-User

7. Europe Functional Genomics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Functional Genomics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End-User
    • 7.3.2. France Functional Genomics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End-User
    • 7.3.3. United Kingdom Functional Genomics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End-User
    • 7.3.4. Italy Functional Genomics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End-User
    • 7.3.5. Spain Functional Genomics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End-User

8. Asia Pacific Functional Genomics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Functional Genomics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End-User
    • 8.3.2. India Functional Genomics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End-User
    • 8.3.3. Japan Functional Genomics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End-User
    • 8.3.4. South Korea Functional Genomics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End-User
    • 8.3.5. Australia Functional Genomics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End-User

9. Middle East & Africa Functional Genomics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Functional Genomics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End-User
    • 9.3.2. UAE Functional Genomics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End-User
    • 9.3.3. South Africa Functional Genomics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End-User

10. South America Functional Genomics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technology
    • 10.2.3. By Application
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Functional Genomics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End-User
    • 10.3.2. Colombia Functional Genomics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End-User
    • 10.3.3. Argentina Functional Genomics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Functional Genomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Agilent Technologies, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Becton, Dickinson and Company
  • 15.3. Bio-Rad Laboratories, Inc.
  • 15.4. Danaher Corporation (Integrated DNA Technologies, Inc.)
  • 15.5. F. Hoffmann-La Roche Ltd.
  • 15.6. Illumina, Inc.
  • 15.7. MRM Proteomics Inc
  • 15.8. Perkin Elmer, Inc.
  • 15.9. QIAGEN N.V.
  • 15.10. ¬¬¬Thermo Fisher Scientific, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer